[go: up one dir, main page]

RU2018121296A - INACTIVATED BIRD REVIRUS VACCINE FOR APPLICATION IN A METHOD FOR INCREASING THE HATCHENESS OF BIRD EGGS - Google Patents

INACTIVATED BIRD REVIRUS VACCINE FOR APPLICATION IN A METHOD FOR INCREASING THE HATCHENESS OF BIRD EGGS Download PDF

Info

Publication number
RU2018121296A
RU2018121296A RU2018121296A RU2018121296A RU2018121296A RU 2018121296 A RU2018121296 A RU 2018121296A RU 2018121296 A RU2018121296 A RU 2018121296A RU 2018121296 A RU2018121296 A RU 2018121296A RU 2018121296 A RU2018121296 A RU 2018121296A
Authority
RU
Russia
Prior art keywords
vaccine
birds
administered
eggs
inactivated
Prior art date
Application number
RU2018121296A
Other languages
Russian (ru)
Other versions
RU2018121296A3 (en
Inventor
ГЕРДТ Петер ДЕ
Хендрик Корнелиус КОПМАН
Original Assignee
Интервет Интернэшнл Б.В.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Интервет Интернэшнл Б.В. filed Critical Интервет Интернэшнл Б.В.
Publication of RU2018121296A publication Critical patent/RU2018121296A/en
Publication of RU2018121296A3 publication Critical patent/RU2018121296A3/ru

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5252Virus inactivated (killed)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/545Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/55Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552Veterinary vaccine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55566Emulsions, e.g. Freund's adjuvant, MF59
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011Details
    • C12N2720/12011Reoviridae
    • C12N2720/12211Orthoreovirus, e.g. mammalian orthoreovirus
    • C12N2720/12234Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Claims (11)

1. Инактивированная вакцина против реовируса птиц для применения в повышении вылупляемости яиц птицы, причем указанную вакцину вводят птицам по меньшей мере два раза до начала яйцекладки.1. Inactivated vaccine against reovirus birds for use in increasing the hatchability of eggs, and the specified vaccine is administered to birds at least twice before the laying of eggs. 2. Инактивированная вакцина против реовируса птиц для применения по п.1, отличающаяся тем, что указанное повышение вылупляемости достигается за счет снижения смертности эмбрионов птицы.2. Inactivated vaccine against reovirus birds for use according to claim 1, characterized in that the specified increase in hatchability is achieved by reducing the mortality of bird embryos. 3. Инактивированная вакцина против реовируса птиц для применения по п.1 или 2, отличающаяся тем, что указанное повышение вылупляемости достигается за счет повышения фертильности птиц.3. Inactivated vaccine against reovirus birds for use according to claim 1 or 2, characterized in that the specified hatching is achieved by increasing the fertility of birds. 4. Инактивированная вакцина против реовируса птиц для применения по любому из пп. 1-3, отличающаяся тем, что указанную вакцину вводят и самкам, и самцам птицы.4. Inactivated vaccine against reovirus birds for use according to any one of paragraphs. 1-3, characterized in that the vaccine is administered to both females and male birds. 5. Инактивированная вакцина против реовируса птиц для применения по любому из пп. 1-4, отличающаяся тем, что указанная вакцина представляет собой эмульсию типа вода-в-масле, содержащую адъювант, и указанную вакцину вводят по меньшей мере два раза, по меньшей мере за одну неделю до начала яйцекладки.5. Inactivated vaccine against reovirus birds for use according to any one of paragraphs. 1-4, characterized in that the vaccine is an emulsion of the type water-in-oil containing adjuvant, and the specified vaccine is administered at least two times, at least one week before the laying of eggs. 6. Применение реовируса птиц в получении вакцины для повышения вылупляемости яиц птицы, в котором указанная вакцина представляет собой инактивированную вакцину против реовируса птиц, и указанную вакцину вводят птицам по меньшей мере два раза по меньшей мере за одну неделю до начала яйцекладки.6. The use of avian reovirus in the preparation of a vaccine for increasing the hatchability of poultry eggs, wherein said vaccine is an inactivated vaccine against avian reovirus, and said vaccine is administered to the birds at least twice at least one week before the laying of eggs. 7. Применение по п.6, отличающееся тем, что указанная вакцина представляет собой эмульсию типа вода-в-масле, содержащую адъювант, где указанную вакцину вводят по меньшей мере два раза по меньшей мере за одну неделю до начала яйцекладки, и указанную вакцину вводят и самкам, и самцам птицы.7. The use according to claim 6, characterized in that said vaccine is a water-in-oil emulsion containing an adjuvant, wherein said vaccine is administered at least two times at least one week before the laying of the egg, and said vaccine is administered both females and males birds. 8. Способ повышения вылупляемости яиц птицы, включающий стадию введения птицам инактивированной вакцины против реовируса птиц по меньшей мере два раза по меньшей мере за одну неделю до начала яйцекладки.8. A method for increasing the hatchability of poultry eggs, comprising the step of administering to the birds an inactivated vaccine against avian reovirus at least twice at least one week prior to egg laying. 9. Способ по п.8, отличающийся тем, что указанная вакцина представляет собой эмульсию типа вода-в-масле, содержащую адъювант, где указанную вакцину вводят по меньшей мере два раза по меньшей мере за одну неделю до начала яйцекладки, и указанную вакцину вводят и самкам, и самцам птицы.9. The method of claim 8, wherein said vaccine is a water-in-oil emulsion containing an adjuvant, wherein said vaccine is administered at least two times at least one week prior to egg laying and said vaccine is administered both females and males birds. 10. Применение инактивированной вакцины против реовируса птиц для повышения вылупляемости яиц птицы, в котором указанную вакцину вводят птицам по меньшей мере два раза до начала яйцекладки.10. The use of an inactivated vaccine against reovirus birds to increase the hatchability of eggs, in which the specified vaccine is administered to birds at least twice before the laying of eggs. 11. Применение по п.10, отличающееся тем, что указанная вакцина представляет собой эмульсию типа вода-в-масле, указанную вакцину вводят по меньшей мере два раза до начала яйцекладки, и указанную вакцину вводят и самкам, и самцам птицы.11. The use of claim 10, wherein said vaccine is a water-in-oil emulsion, said vaccine is administered at least two times before the laying of eggs, and said vaccine is administered to both females and male birds.
RU2018121296A 2015-11-12 2016-11-11 INACTIVATED BIRD REVIRUS VACCINE FOR APPLICATION IN A METHOD FOR INCREASING THE HATCHENESS OF BIRD EGGS RU2018121296A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP15194339 2015-11-12
EP15194339.6 2015-11-12
PCT/EP2016/077400 WO2017081232A1 (en) 2015-11-12 2016-11-11 Inactivated avian reovirus vaccine for use in a method to increase the hatchability of poultry eggs

Publications (2)

Publication Number Publication Date
RU2018121296A true RU2018121296A (en) 2019-12-13
RU2018121296A3 RU2018121296A3 (en) 2020-01-29

Family

ID=54544947

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2018121296A RU2018121296A (en) 2015-11-12 2016-11-11 INACTIVATED BIRD REVIRUS VACCINE FOR APPLICATION IN A METHOD FOR INCREASING THE HATCHENESS OF BIRD EGGS

Country Status (4)

Country Link
EP (1) EP3373966A1 (en)
CN (1) CN108348597A (en)
RU (1) RU2018121296A (en)
WO (1) WO2017081232A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11813321B2 (en) 2018-07-13 2023-11-14 Biomune Company Vaccines against avian reoviruses
CN112080477B (en) * 2020-05-09 2023-05-16 重庆三杰众鑫生物工程有限公司 Duck reovirus and preparation method and application of antigen-antibody complex thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4559229A (en) * 1982-07-20 1985-12-17 Research Foundation Avian proventriculitis vaccine
EP2304024A2 (en) * 2008-06-26 2011-04-06 Biomune Company Avian reoviridae

Also Published As

Publication number Publication date
EP3373966A1 (en) 2018-09-19
CN108348597A (en) 2018-07-31
RU2018121296A3 (en) 2020-01-29
WO2017081232A1 (en) 2017-05-18

Similar Documents

Publication Publication Date Title
LT3523649T (en) AUTOMATIC NON-INVASIVE DETERMINATION OF BIRD EGG FERTILITY
BR112019003222A2 (en) spirals and heart valve docking systems
UY35851A (en) ? VACCINATION SYSTEM FOR THE ADMINISTRATION OF VACCINES TO CHICKENS AND ASSOCIATED PROCEDURES AND DEVICES.
PL3439466T3 (en) Method and device for optical in ovo sex determination of fertilized and incubated birds' eggs
AR103217A1 (en) SYSTEM AND METHOD TO VACCINE BIRDS OF CORRAL
IL281990A (en) Subcutaneous administration and administration of ANTI-C5 antibodies for the treatment of paroxysmal nocturnal hemoglobinuria (PNH)
HK1225226A1 (en) Selective embryonic structure targeting and substance delivery device
CL2016001113A1 (en) Method for the production of infertile fish and aquatic animals that produce eggs and for the administration of compounds in eggs and embryos
MX2022009736A (en) P2X<sub>3</sub> AND/OR P2X<sub>2/3</sub> COMPOUNDS AND METHODS.
CO2017002614A2 (en) Emulsified vaccine to obtain concentrated igy immunoglobulin formulations; processes and uses thereof.
BR112018077210A8 (en) Duck enteritis virus and uses thereof
MX2016015166A (en) METHOD AND DEVICE FOR CONDITIONAL IN OVO INJECTION.
MX2016016885A (en) IN OVO ADMINISTRATION OF PROBIOTIC CROPS.
RU2018121296A (en) INACTIVATED BIRD REVIRUS VACCINE FOR APPLICATION IN A METHOD FOR INCREASING THE HATCHENESS OF BIRD EGGS
Muir et al. Genetic influences on the behavior of chickens associated with welfare and productivity
RU2019137459A (en) Vaccines Based on Bird Reoviruses
MX2017009796A (en) MDV1 RECOMBINANTS AND USES OF THE SAME.
BR112019002210A2 (en) method to control avian coccidiosis
TH1801002807A (en) Inactivated poultry rheovirus vaccine for use as a means to increase capacity In the incubation of poultry eggs
RU2014109555A (en) METHOD FOR INCREASING AND SYNCHRONIZING OUTPUT OF CHICKENS BY MEANS OF PREVENTION OF OXIDATIVE STRESS IN CHICKEN EMBRYOS
CL2021001236A1 (en) Double egg-based emulsions and procedure to prepare them.
RU2015157320A (en) METHOD FOR PREVENTING VIRAL BIRD DISEASES
AR101474A1 (en) INHIBITING SEMIOCHEMICAL COMPOSITION OF THE SETTING OF COPEPODITES OF PIOJOS DE MAR
Presentado et al. Levels of vaccinal antibodies against Gumboro disease in 21 and 28 post-birth day broiler chickens.
MX2021005257A (en) IMMUNOGENIC COMPOSITION AGAINST THE H5 SUBTYPE OF THE AVIAN INFLUENZA VIRUS.